(GSUS) Goldman Sachs MarketBeta US - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US3814301236 • Large Blend
GSUS: Stocks, Index Funds, Equity Securities, Depositary Receipts
GSUS, the Goldman Sachs MarketBeta US Equity ETF, is designed for investors seeking broad exposure to U.S. equities with a focus on large and mid-capitalization companies. The fund invests at least 80% of its assets in securities from its underlying index, which tracks the performance of the largest publicly traded U.S. companies. This includes depositary receipts and the underlying stocks they represent, ensuring a diversified portfolio that mirrors the indexs composition.
The underlying index is structured to cover approximately 85% of the free-float market capitalization in the U.S., providing a comprehensive representation of the domestic equity market. This approach allows GSUS to capture the performance of a wide range of sectors and industries, making it a suitable choice for investors looking to gain exposure to the overall U.S. market without concentrating on specific sectors or individual stocks.
As a large blend ETF, GSUS offers a balance between growth and value stocks, appealing to investors who prefer a neutral, market-weighted approach. The funds expense ratio and tracking error are important considerations for investors evaluating its cost efficiency and ability to replicate the indexs performance accurately. Historically, GSUS has demonstrated low tracking error, indicating effective replication of its benchmark.
For fund managers, GSUS serves as a valuable tool for portfolio construction, enabling quick and efficient exposure to the U.S. large-cap market. Its liquidity and transparency make it an attractive option for tactical allocations or as a core holding in a diversified portfolio. Additionally, GSUS can be used to rebalance portfolios or to gain exposure during specific market conditions without the need for individual stock selection.
Investors should evaluate GSUS based on their investment objectives, risk tolerance, and time horizon. While the fund provides broad market exposure, it does not offer the potential for outperformance relative to the market, as it is designed to track its index. As with any investment, its essential to review the funds prospectus, including details on fees, holdings, and investment strategies, to ensure alignment with personal investment goals.
Additional Sources for GSUS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GSUS ETF Overview
Market Cap in USD | 2,397m |
Category | Large Blend |
TER | 0.07% |
IPO / Inception | 2020-05-12 |
GSUS ETF Ratings
Growth 5y | 82.8% |
Fundamental | - |
Dividend | 61.6% |
Rel. Strength Industry | 0.21 |
Analysts | - |
Fair Price Momentum | 76.74 USD |
Fair Price DCF | - |
GSUS Dividends
Dividend Yield 12m | 1.24% |
Yield on Cost 5y | 2.61% |
Annual Growth 5y | 18.69% |
Payout Consistency | 100.0% |
GSUS Growth Ratios
Growth Correlation 3m | -21% |
Growth Correlation 12m | 90.8% |
Growth Correlation 5y | 79.9% |
CAGR 5y | 16.84% |
CAGR/Max DD 5y | 0.66 |
Sharpe Ratio 12m | 1.69 |
Alpha | 0.24 |
Beta | 1.01 |
Volatility | 25.33% |
Current Volume | 54.9k |
Average Volume 20d | 47.8k |
As of March 18, 2025, the stock is trading at USD 78.09 with a total of 54,900 shares traded.
Over the past week, the price has changed by +1.35%, over one month by -7.59%, over three months by -6.10% and over the past year by +11.89%.
Yes. Based on ValueRay Analyses, Goldman Sachs MarketBeta US (BATS:GSUS) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 82.81 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GSUS as of March 2025 is 76.74. This means that GSUS is currently overvalued and has a potential downside of -1.73%.
Goldman Sachs MarketBeta US has no consensus analysts rating.
According to ValueRays Forecast Model, GSUS Goldman Sachs MarketBeta US will be worth about 88.7 in March 2026. The stock is currently trading at 78.09. This means that the stock has a potential upside of +13.61%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 88.7 | 13.6% |